— Know what they know.
Not Investment Advice
Also trades as: NRSN (NASDAQ) · $vol 0M

NRSNW Earnings

NeuroSense Therapeutics Ltd.
1W: -55.6% 1M: +1.3% 3M: -72.4% YTD: -86.7% 1Y: -93.7% 3Y: -88.2%
$0.04
-0.01 (-11.11%)
 
Weekly Expected Move ±85.5%
$-0 $0 $0 $0 $0
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 58 · $986667 mcap · 16M float · 0.0095% daily turnover · Short 35% of daily vol
Last Earnings 2026-03-31
EPS
$-0.22
▼ Miss -210.7%
Revenue
—
Next Earnings 2026-12-02
EPS Estimate
$-3.17
Range: $-3.17 - $-3.17
Revenue Estimate
$278K
1 analysts

Estimate vs Actual

Earnings Surprise History

2/4
EPS Beats
0/4
Revenue Beats
50%
EPS Beat Rate
0%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-09-29 annual 2030-12-31 $18.60 $7.49 ▼ 11.11 $162,500,000 $162,500,000
2026-09-29 annual 2027-12-31 $-11.47 $-10.31 ▲ 1.16 $3,277,900 $3,277,900
2026-09-29 annual 2028-12-31 $-13.60 $-7.58 ▲ 6.02 $10,000,000 $10,000,000
2026-09-29 annual 2026-12-31 $-7.60 $-6.62 ▲ 0.98 $714,067 $714,067
2026-09-29 quarter 2026-12-30 $-3.60 $-3.17 ▲ 0.43 $278,500 $278,500
2026-09-29 annual 2029-12-31 $9.00 $13.19 ▲ 4.18 $21,400,000 $21,400,000
2026-09-15 annual 2030-12-31 $0.93 $18.60 ▲ 17.67 $162,500,000 $162,500,000
2026-09-15 quarter 2027-03-30 $-0.05 $-0.95 ▼ 0.90 $1,573,400 $1,573,400
2026-09-15 annual 2028-12-31 $-0.68 $-13.60 ▼ 12.92 $10,000,000 $10,000,000
2026-09-15 annual 2026-12-31 $-0.38 $-7.60 ▼ 7.22 $714,067 $714,067
2026-09-15 quarter 2027-12-30 $-0.34 $-6.90 ▼ 6.56 $1,704,500 $1,704,500
2026-09-15 quarter 2027-09-30 $-0.05 $-0.97 ▼ 0.92 $1,639,000 $1,639,000
2026-09-15 quarter 2026-12-30 $-0.18 $-3.60 ▼ 3.42 $278,500 $278,500
2026-09-15 quarter 2025-12-30 $-0.07 $-1.42 ▼ 1.35 $— $—
2026-09-15 quarter 2028-12-30 $-0.08 $-1.54 ▼ 1.46 $3,477,500 $3,477,500
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms